United Therapeutics Corp (UTHR)
358.53
+0.81
(+0.23%)
USD |
NASDAQ |
Sep 27, 16:00
358.67
+0.14
(+0.04%)
After-Hours: 20:00
United Therapeutics SG&A Expense (TTM): 581.80M for June 30, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 581.80M |
March 31, 2024 | 534.20M |
December 31, 2023 | 477.10M |
September 30, 2023 | 508.10M |
June 30, 2023 | 478.90M |
March 31, 2023 | 490.40M |
December 31, 2022 | 482.10M |
September 30, 2022 | 446.80M |
June 30, 2022 | 457.50M |
March 31, 2022 | 428.80M |
December 31, 2021 | 467.00M |
September 30, 2021 | 497.80M |
June 30, 2021 | 455.00M |
March 31, 2021 | 448.10M |
December 31, 2020 | 423.90M |
September 30, 2020 | 370.40M |
June 30, 2020 | 403.50M |
March 31, 2020 | 337.20M |
December 31, 2019 | 336.20M |
September 30, 2019 | 310.20M |
June 30, 2019 | 320.90M |
March 31, 2019 | 364.40M |
December 31, 2018 | 265.80M |
September 30, 2018 | 345.70M |
June 30, 2018 | 282.80M |
Date | Value |
---|---|
March 31, 2018 | 267.10M |
December 31, 2017 | 330.10M |
September 30, 2017 | 310.50M |
June 30, 2017 | 363.40M |
March 31, 2017 | 368.20M |
December 31, 2016 | 316.80M |
September 30, 2016 | 326.00M |
June 30, 2016 | 208.60M |
March 31, 2016 | 246.40M |
December 31, 2015 | 452.70M |
September 30, 2015 | 384.55M |
June 30, 2015 | 604.35M |
March 31, 2015 | 562.38M |
December 31, 2014 | 381.30M |
September 30, 2014 | 457.93M |
June 30, 2014 | 349.54M |
March 31, 2014 | 352.87M |
December 31, 2013 | 394.01M |
September 30, 2013 | 276.90M |
June 30, 2013 | 251.42M |
March 31, 2013 | 233.31M |
December 31, 2012 | 201.75M |
September 30, 2012 | 219.38M |
June 30, 2012 | 167.41M |
March 31, 2012 | 138.01M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
310.20M
Minimum
Sep 2019
581.80M
Maximum
Jun 2024
446.75M
Average
456.25M
Median
SG&A Expense (TTM) Benchmarks
Liquidia Corp | 67.90M |
Catalent Inc | 935.00M |
Amgen Inc | 7.22B |
Merck & Co Inc | 10.54B |
AbbVie Inc | 13.26B |